Journal of the Pancreas is rated as the top journal on Cystic fibrosis. Journal of the pancreas has got its uniqueness in publishing the ingenious and the most upgraded research information in the form of editorials and review articles.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects the lungs, pancreas, liver, and intestine. Its main characteristic is disrupted transport of chloride and sodium across an epithelium, which leads to thick, viscous secretions. It is also known as mucoviscidosis. Abnormal breathing is the most serious symptom which results from frequent lung infections. Cystic fibrosis is caused by a frameshift mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator. (CFTR). The name cystic fibrosis was given because there is a cyst formation in the Pancreas. The thick mucus secretion occurring due to cystic fibrosis block the way of digestive and endocrine enzymes of pancreas, causing a complete damage to pancreas.
Journal of the Pancreas has been acquired and being published by one of the leading Open Access publishers in the world i.e. OMICS International. OMICS International has been successful in managing more than 700+ peer-reviewed journals with the help of 50,000+ editorial board members, serving the requirements of 15 million readers. Along with open access publication, OMICS Group has been successful in organizing International conferences around the globe annually. With a vision to make healthcare and scientific information open access OMICS Group has team up with more than 100 renowned associations worldwide.
Last date updated on June, 2014